Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.725
+0.015 (0.55%)
Jun 8, 2026, 1:15 PM EDT - Market open
Altimmune Market Cap
Altimmune has a market cap or net worth of $529.94 million as of June 8, 2026. Its market cap has increased by 16.88% in one year.
Market Cap
529.94M
Enterprise Value
231.33M
1-Year Change
16.88%
Ranking
Category
Stock Price
$2.73
Market Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $529.94M, a decrease of -75.82%. That is a compound annual growth rate of -14.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 527.02M | 33.75% |
| Dec 31, 2025 | 394.05M | -23.16% |
| Dec 31, 2024 | 512.81M | -15.16% |
| Dec 29, 2023 | 604.45M | -25.23% |
| Dec 30, 2022 | 808.45M | 122.62% |
| Dec 31, 2021 | 363.14M | -12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 553.77M |
| Immix Biopharma | 553.44M |
| Prime Medicine | 552.69M |
| Tectonic Therapeutic | 547.21M |
| ProKidney | 543.71M |
| Ginkgo Bioworks Holdings | 536.97M |
| Cabaletta Bio | 529.93M |
| XOMA Royalty | 527.85M |